Opko Health Inc【OPK】株式ニュース

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell...

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) today announced that its...

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- BioReference® Health LLC, an OPKO Health, Inc. company...

Form 8-K - Current report

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights...

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize...

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

MIAMI, April 21, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and...

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

WESTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ:...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

PirateSentinel32 3週前

OPKO has an AWESOME pipe!!

👍️0

BottomBounce 1年前

New study: The Cleveland Clinic found that the influenza vaccine was not effective last winter

“It had a negative efficacy of 26.9%. In other words, if you took this flu vaccine, you were 26.9% more likely to get influenza”

Big Pharma makes $6.3 billion annually on this vaccine pic.twitter.com/V6NCzkp22E— Wall Street Apes (@WallStreetApes) May 26, 2025 $OPK

👍️0

OPKOHEALTH2022 1年前

Looks like it’s time to buy back !

👍️0

tredenwater2 1年前

Im not sure about any other Frost/Opko investments, some of which they got their hand slapped for “promoting”, but Chromadex, now ticker symbol NAGE is looking like its on a solid footing with increasing revenue.

With all of Dr. Frosts financial and COB management experience, how is it Opko has been such a disaster? “It” was either planned the entire way or Dr. Frosts “future friends” are taking their sweet time cozying up to their old friend this time around…..imo nothing in the middle.

👍️0

MIKE18181 1年前

ROE has not happened, this is Corporate responsibililty. Frost is not a finance guy. Hes frail since 2006

👍️0

homeboy 1年前

Sold our position for a 70% gain. Will buy it back if it comes lower. Selling the lab will be a catalyst. I don’t see that happening soon. OPKO is set to lose somewhere in the vicinity of 140 million for the remainder of the year and with the debt on hand and the 300 million plus share dilution, for us, seemed like a good time to exit.

👍️0

homeboy 1年前

I disagree Mike. Their WGS investment is way of making profit. Not all entities within the business are losses. I strongly believe that if they can, and the word can is key, sell the lab for say a billion the stock will go up dramatically. They need to get the lab on all cylinders to be interesting for a potential suitor. With a lab sale (at least a billion), all debt could be repurchased, except for the notes..which Frost and Friends will want to keep IMO. The business WILL be sold at some point. I have no doubt about it. Frost sounded frail on the conference call..he’s nearly 90.

👍️0

MIKE18181 1年前

Opk- Regarding net income : One time gain on the sales of WGS stock was 52 million. Also other income added to the 4th Quarter net inco.e statement. " Trickery ".. Opko lost approximatly 62 million. Net income +.01 cent of 14 million is like watching a comedy show. More deceit for Honest shareholders..

👍️0

MIKE18181 1年前

Funeral home has more action than Opko, geez what a. Giant bag of Phlem

👍️0

homeboy 1年前

If it closes above 1.75 it should establish a higher trading range.

👍️0

game7alcs 1年前

For anybody still here Hindenburg closed shop. One of OPKOs old short sellers. I must be bored to post here. Hope most of you got out.

👍️0

JJ8 1年前

Opko share price Low Pole Reversal on 31-Dec-2024. Surprise, surprise.
This is positive and could reverses price to a breakout!

👍️0

JJ8 1年前

Opko Health Inc. share price had a Descending Triple Bottom Breakdown on 27-Dec-2024.
Day order to buy at $1.40. I don't know why.

👍️0

homeboy 1年前

Shorts are not covering because they are hedging with options..that’s my thoughts.

👍️0

PonkenPlonken 2年前

Clear tug of war here
Why does crooked Mr Frost continue to buy shares? And why do shorts not leave? About 30% of the float has been sold short, practically for ages.

👍️0

homeboy 2年前

EARNINGS: will probably show a profit with the part lab sale if they can Mickey Mouse the accounting. Cash reserve will be strong, but the real key is the forecast with the lab. Frost with his pig headed stubbornness has held on to this money sucking failure to OPKO’s demise. From nearly 20 at the time of purchasing the lab to a penny stock now.
Poor management …company runs on Frost’s money and not on making money.

👍️0

tredenwater2 2年前

He can sell and leave yet, Dr. Frost needs to batten down the hatches on Star Island at his 60-80(?) million dollar mansion first from the ensuing Hurricane.

Almost like its Gods cleansing mechanism.

👍️0

MIKE18181 2年前

Sell the company Phil and Leave the planet !

👍️0

tredenwater2 2年前

Nice throwback. So, the gentleman that wrote the article back in 2019 (who was short on more than a few of Frost/honig stocks) was possibly a future “friend” of Frosts as he was quoted assaying in his past endeavors how many of those that bet against me (ie shorts) ended up becoming friends with him in the end.

👍️0

homeboy 2年前

https://hindenburgresearch.com/opko-health-if-these-sec-charges-were-surprising-then-you-havent-been-paying-attention/

Old article..some relevance today

👍️0

MIKE18181 2年前

Yes, his age woukd be a reason also.
If its gonna do anything it soon.

👍️0

homeboy 2年前

Seems like the same story..we think they are setting up to sell the company. After the part sale closes, the remaining part of the lab could be sold to some other entity and Opko would become a research and development company (Modex). As a stand alone like this, it would be attractive to other pharma companies. We’ll be trading this from here on out. Synergies have momentum to the upside time being.

👍️0

MIKE18181 2年前

Accounting made the -10m loss look smaller.
Curveball acconting since you like baseball. Closing of BRL not yet, so streamling was Not the real reason. Why, easy one you would have seen a loss in revenue as assets were sold.
So - 25,000,000 per quater minus axtual revene.
^Remember 100m in revs gone, as the unloaded BRL business segment.. 10% buy back is needed as the Dead Dog is obese with too many shares..

👍️0

game7alcs 2年前

I decided to listen to todays call. It’s like listening to a call 10 years ago with different promising pipelines or should I say pipe dreams. Put your money to work elsewhere. You will be able to come back years from now and buy at these prices with your profits from actual investments.

👍️0

MIKE18181 2年前

Bottom Line is the Bottom Line !
No earnings= No Action.

👍️0

homeboy 2年前

We expect some short covering with today’s news. Not earth shattering news, but positive in the short term.

👍️0

homeboy 2年前

WGS on the move higher and higher. This gives OPKO some much needed cash. It will be interesting to see how the part lab sale will affect the rest of the lab share OPKO retains…will they finally start making a consistent profit?

👍️0

homeboy 2年前

Hey Mike. I think the 80 million is the value of their holdings in WGS. Not bad,

👍️0

MIKE18181 2年前

Frost made Money by having others perform the Finance. Hes Incompetant look at the resulrs. Frost got a free ride of otjers expertise.He is a Liar, farce, bullshetter.m He nows zip about financial mgmt. Hes a Fraud, and harmed shareholders. Going concern rating on broke Opk is a FACT !! A Fact !!!

👍️0

MIKE18181 2年前

IMO, the 80million shares of Genedx is going to be unloaded. Word on the street is Opko is insolvent.. 155m in adj revenue and - 81million loss this is a horror show.

👍️0

game7alcs 2年前

Hey Tred, good to hear from you. Yea it’s kind of a moot point that regardless of what is going on here, the shareholders are the ones getting the shaft. As usual.

👍️0

homeboy 2年前

OPK (Opko) short interest is very high.

👍️0

homeboy 2年前

Current Issues with OPK:
1). The part lab sale will lead to more cash on hand, but will it lead to better management and profitability of the remaining lab structure? 2) OPK last quarter issued 250 million shares to the treasury. OPKO is running out of cash on hand and will use these shares to fuel the company if needed. 3). WE expect that if the sale of the part lab is not done before the next conference call the stock will sell off and investors will take a wait and see approach.

👍️0

tredenwater2 2年前

Game and Mike there is a possible chance that HF’s and other BP are suppressing the shareprice as a takeover maneuver to get at Opko’s IP. Dr. Frost Im sure has made or attracted many “future friends” along the way. History and God will be his judge and yes, I feel sorry for those that over invested and got taken to the cleaners and agree that not holding ones breath waiting for the halls of justice to save us is a good idea. We are but sucker fish on the smallest of bait in the sea when it comes to their priorities if ever.

Cheers

Tred

👍️0

game7alcs 2年前

If you think Dr Frost is corrupt you should take a look at our DOJ, SEC and other govt agencies. They make Dr Frost look like Mother Theresa. They aren’t going to help the shareholders here recover from a bad investment in a highly speculative company.

👍️0

MIKE18181 2年前

Department of justice (DOJ, SEC and more). We dont want an anti trust or monopoly or unfair business / competion that hurts consumers !!!

Ok, listen.. but you allow a CEO Phillip Frost to control the common stock, Mislead, Lie , Harm hardworkibg shareholders..
Look at the results since 2006.
Should have been fired for losses to all Opk shareholders. " to be held accoutable for lack of performance "...

👍️0

MIKE18181 2年前

Takeout price is 3.00 IMO

👍️0

homeboy 2年前

Looks like a positive turn of events while we were away. They are setting this up for an eventual sale..perhaps not this year, but I think it’s coming. Probably an all stock offer from some other Pharma company. I don’t see anyone offering them cash for a company that hasn’t and isn’t making money. This endeavor for the Dr. has been a colossal failure for most investors. A lot of hype over the years and not delivering on the goods. Take care everyone. We’ll hold our position until we see a good exit point.

👍️0

tredenwater2 2年前

Makes one wonder after looking at the trading pattern of CDXC (whom Dr. Frost is connected with) if OPK will do the same in the near future. Transfer of wealth in a very coordinated manner imo.

👍️0

tredenwater2 2年前

What a shet show! Millions and millions of shares trade on Monday and 10 million plus today and the stock barely climbs. Let me guess, it was a quadruple whitching Monday and the moon was full? I have to admit I have never seen trading like this, is this even legal?

This stock is flat out evil. Whoever is manipulating it is surely going to hell in a hand basket. Outright greed imo strip mining shareholders of absolutely any chances here. Not even fun to watch the crazy shenanigans going on.

Ive lost the last 2.5% respect I had for Dr. Frost and team of which 1.5% of it was for Dr. Jane Hasao. They could solve world hunger and I wouldnt even bat an eye. This is text book bullshet!

👍️0

tredenwater2 2年前

If that is true it is very sad to hear Mike. I lost money a couple of times but was able to profit very early in 2015/16 before the HFT AI trading took over. You are but one of many that have been systematically “cycled” out of their money. The trading of this stock appears to be so robotic, almost programmed through AI squeezing every last penny out of investors. Maybe one day Dr. Frost will have to answer here on earth for why he was so incompetent at the helm of a company he holds and continues to buy many millions of shares of stock of.

Do not worry, God will “settle” his trades.

Happy Easter!

Tred

👍️0

MIKE18181 2年前

I sold every Opko share and Lost 437,000 dollars and my retirement money is all gone.
I sold all of it at 90 cents down to 86 cents.
Wiped out.. and then it went up to 1.25
Even at 1.25 I still lost 95 % .
Frost got away with it! SEC would not award me 1.00 buck

👍️0

MIKE18181 2年前

88 cents and dropping. Chart momentum was showing it even with Frost buying.
Not looking good.

👍️0

MIKE18181 2年前

Yes, I wrote about Yvonne Briggs IR, and said as I asked a simple question, I started to probe other harder.
Result backed off, and told me to read the Q reports . I called you, because you the Investir relation support. I got more calls gotta go.
This will be sold and the time frame to me looks like 2 qtrs

👍️0

homeboy 2年前

The reason we ask questions directly to management is there is an underlying tone that is not open with this company. I highlighted that with Adam Logal during the conference call mentioning the repurchase of shares. That was a deflection from what was really going on… Yvonne tries to come across as being open at the investor relations department. As a former business owner, I can assure you what you get from investor relations is scripted to what has been publicly released only. Behind the scenes is a different world. We (our team of investors) are betting on some type of buyout. Elias is in his 70s, Frost is near 90. Those are the main characters. Both cut from the same mold…grow the business, then sell it. Very common practice.
What Yvonne tells about the current outstanding shares is only part of the story. In a buyout, many of those reserved shares would also have to be honored. So, being conservative 1,000,000,000 shares at this point would be the buyout amount. For example: a buyout at 7 dollars would represent a 7 billion dollar purchase. Modex has value potential we think. As many here have said, the lab has been a nemesis and OPKO has not reacted fast enough. There was a reason the former owner was happy to sell Bio for 1.5 billion. We can see clearly now. But what remains a mystery is why OPKO continues to fund it at a deficit in the hundreds of millions? On another note…
We will be traveling for a while until mid June to China. Until then, hopefully OPKO will have some good fortune during the interim.

👍️0

MIKE18181 2年前

Good information Homeboy, I talk about that a while back. I knew that the casflow statements and Income statement never were fixed.... Issuance was the only quick savior.
This 1,000,000 share buying is not going to solve the perception from the destroyed Audience.
A sold company would...

👍️0

homeboy 2年前

I inquired about the specifics to increase the share count:

“The Board has unanimously adopted and declared advisable, and has recommended that the Company's stockholders approve, the Charter Amendment, which would amend the Certificate of Incorporation to increase the number of authorized shares of common stock from 1,000,000,000 to 1,250,000,000.

In addition to the 726,764,700 shares of common stock issued and outstanding (including treasury shares) as of the record date, the Board has reserved an aggregate of 418,733,078 additional shares for future issuance, consisting of the following: (a) 53,731,069 shares reserved for issuance upon the exercise of outstanding employee stock options; (b) 32,912,579 shares reserved for future issuance of awards under the 2016 Equity Incentive Plan; (c) 48,295 shares reserved for issuance upon conversion of the Company's outstanding 4.50% convertible senior notes due 2025 issued in February 2019; (d) 8,489 shares reserved for issuance upon conversion of the Company's outstanding 2033 convertible senior notes issued in January 2013; and (e) 332,032,646 shares reserved for issuance upon conversion of the Company's outstanding 3.75% Convertible Senior Notes due 2029 issued in January 2024.

As a result, the Company currently has no authorized but unissued shares of common stock (including treasury shares) that are unreserved and available for future issuance.”

👍️0

MIKE18181 2年前

This stock Opko is getting spanked , I hope something is coming. . 775m @ 2bucks 3 4 5 6 7 8 × the outstanding or unload BRL.
Genedx holdings went way up after 1.16 slide.
So, they don't need just cash they need a SANE financial plan..

👍️0

game7alcs 2年前

Dr Frost has absolutely nothing zero nadda up his sleeve. I check back once in a while and still the same nonsense. Sell. Get out with what little you have left.

👍️0

homeboy 2年前

Frost must have something up his sleeve. He alluded to that without letting the cat out of the bag during the conference call. We are holding our position. A little under water.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Opko Health Inc (OPK)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Opko Health Inc (OPK) ニュース

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

Form 8-K - Current report

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

OPK Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Opko Health Inc (OPK)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Opko Health Inc (OPK) ニュース

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

Form 8-K - Current report

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

OPK Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する